Ephraim Vidal, Ph.D., Director of Pharmaceutical Development
Dr. Vidal has sixteen years of experience in the pharmaceutical industry as a pharmaceutical development scientist. He has led the development of drug substance manufacturing from the early stages through commercial manufacturing.
He has worked for Aventis, Sanofi-Aventis and Hospira in various drug substance process development roles. Dr. Vidal currently manages external process development and drug substance manufacturing in contract research and manufacturing organizations.
Dr. Vidal obtained his Ph.D. in Chemistry at Stony Brook University in New York and had postdoctoral training at Stony Brook University and Memorial Sloan-Kettering Cancer Center.